Master Class: Prostate Cancer Screening and Diagnosis

Thursday, October 30, 2025

11:15 - 12:45 GMT+0

Co-Chair(s)

Simpa Salami

Associate Professor of Urology
University of Michigan, United States
Caroline Moore

NIHR Research Professor & Head of Urology
University College London, United Kingdom

At the end of this session, attendees should be able to:

Apply shared decision-making principles to prostate cancer screening and early detection.
Compare the diagnostic performance of MRI and micro-ultrasound in prostate cancer detection.
Analyze advantages and limitations of transperineal and transrectal biopsy approaches.
Recall the role of emerging biomarkers for prostate cancer early detection.
Recognize differing prostate cancer diagnostic pathways associated with different resource availability worldwide.

11:15 - 11:27 GMT+0

Shared Decision Making for Prostate Cancer Early Detection
Speaker: Monique Roobol – Erasmus Medical Center, Cancer Institute
11:27 - 11:39 GMT+0

MRI vs Micro U/S for Prostate Cancer Diagnosis
Speaker: Laurence Klotz – Sunnybrook Research Institute
11:39 - 11:51 GMT+0

TRANSFORM Trial
Speaker: Caroline Moore – University College London
11:51 - 12:03 GMT+0

Prostate Biopsy TP vs TR
Speaker: Alastair D. Lamb – Barts Cancer Institute & Guys Hospital
12:03 - 12:15 GMT+0

Biomarkers for Prostate Cancer Early Detection
Speaker: Simpa S. Salami – University of Michigan
12:15 - 12:27 GMT+0

Prostate Cancer Diagnostic Pathway in LMIC
Speaker: Shingai Mutambirwa – Sefako Makgatho Health Sciences University
12:27 - 12:45 GMT+0

Discussion and Concluding Remarks